Invention Grant
- Patent Title: Lactam compound as FXR receptor agonist
-
Application No.: US16616632Application Date: 2018-05-25
-
Publication No.: US11339147B2Publication Date: 2022-05-24
- Inventor: Haiying He , Jun Yu , Shuhui Chen
- Applicant: CSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO., LTD.
- Applicant Address: CN Shijiazhuang
- Assignee: CSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO., LTD.
- Current Assignee: CSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY (SHIJIAZHUANG) CO., LTD.
- Current Assignee Address: CN Shijiazhuang
- Agency: Parker Highlander PLLC
- Priority: CN201710384773.8 20170526,CN201710523080.2 20170626,CN201710867863.2 20170922
- International Application: PCT/CN2018/088393 WO 20180525
- International Announcement: WO2018/214959 WO 20181129
- Main IPC: C07D413/14
- IPC: C07D413/14 ; C07D413/12 ; A61P1/16 ; C07D417/14 ; C07D471/04
Abstract:
Disclosed is a compound as shown in formula (I), an optical isomer thereof or a pharmaceutically acceptable salt thereof, and the present invention relates to the use of same in the preparation of a drug for treating FXR-related diseases.
Information query
